Feng P, Li TL, Guan ZX, Franklin RB, Costello LC: Effect of zinc

Feng P, Li TL, Guan ZX, Franklin RB, Costello LC: Effect of zinc on prostatic tumorigenicity in nude mice. Ann N Y Acad Sci 2003, 1010: 316–320.CrossRefPubMed 7. Costello LC, Franklin RB, Liu Y, Kennedy

MC: Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria. J Inorg Biochem 2000, 78 (2) : 161–165.CrossRefPubMed 8. Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC: Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate PF-6463922 chemical structure cells. J Inorg Biochem 2003, 96 (2–3) : 435–442.CrossRefPubMed 9. Desouki MM, Geradts J, Milon B, Franklin RB, Costello LC: hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 2007, 6: 37.CrossRefPubMed

10. Habib FK, Mason MK, Smith PH, Stitch SR: Cancer of the prostate: early diagnosis by zinc and hormone analysis? Br J Cancer 1979, MAPK Inhibitor Library chemical structure 39 (6) : 700–704.PubMed 11. Costello LC, Franklin RB: Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998, 35 (4) : 285–296.CrossRefPubMed 12. Costello LC, Franklin RB, Feng P: Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion 2005, 5 (3) : 143–153.CrossRefPubMed 13. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P: Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999, 40 (3) : 200–207.CrossRefPubMed Methamphetamine 14. Costello LC, Feng P, Milon B, Tan M, Franklin RB: Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 2004, 7 (2) : 111–117.CrossRefPubMed 15. Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, Ramazzotti V, Tavani A, Dal Maso L, La Vecchia C: Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 2007, 52 (4) : 1052–1056.CrossRefPubMed 16. Ronowska A, Gul-Hinc S, Bielarczyk H, Pawelczyk T, Szutowicz A: Effects of zinc on SN56 cholinergic neuroblastoma

cells. J Neurochem 2007, 103 (3) : 972–983.CrossRefPubMed 17. Dubi N, Gheber L, Fishman D, Sekler I, Hershfinkel M: Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells. Carcinogenesis 2008, 29 (9) : 1692–1700.CrossRefPubMed 18. Franklin RB, Costello LC: Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 2007, 463 (2) : 211–217.CrossRefPubMed 19. Sobel RE, Sadar MD: Cell lines used in prostate cancer research: a compendium of old and
s – part 1. J Urol 2005, 173 (2) : 342–359.CrossRefPubMed 20. Yang M, Loda M, Sytkowski AJ: Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines. Cancer Res 1998, 58 (16) : 3732–3735.PubMed 21.

Comments are closed.